Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 240.87M | $ 2.79M | $ 0 | -1.16% |
3/31/2025 | $ 83.54M | $ 1.23M | $ 0 | -1.47% |
12/31/2024 | $ 77.08M | $ 1.23M | $ 0 | -1.59% |
9/30/2024 | $ 172.6M | $ 376K | $ 0 | -0.22% |
6/30/2024 | $ 140.13M | $ 10.41M | $ 0 | -7.43% |
3/31/2024 | $ 190.17M | $ 10.03M | $ 0 | -5.28% |
12/31/2023 | $ 147.95M | $ 10.03M | $ 0 | -6.78% |
9/30/2023 | $ 120.6M | $ 10.03M | $ 0 | -8.32% |
6/30/2023 | $ 88.78M | $ 0 | $ 0 | 0% |
3/31/2023 | $ 97.71M | $ 0 | $ 0 | 0% |
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for GALECTIN THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 1.17M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 143.83M ]
(=) Payout Yield [ -0.81% ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |